SMLR Quote, Financials, Valuation and Earnings

LifeMD, Inc. has a net margin of -732.34% compared to Semler Scientific, Inc.'s net margin of -5.91%. Semler Scientific, Inc.'s return on equity of 18.3% beat LifeMD, Inc.'s return on equity of --.

Semler Scientific, Inc. has a consensus price target of $65.67, signalling upside risk potential of 221.27%. On the other hand LifeMD, Inc. has an analysts' consensus of $9.25 which suggests that it could grow by 148.66%. Given that Semler Scientific, Inc. has higher upside potential than LifeMD, Inc., analysts believe Semler Scientific, Inc. is more attractive than LifeMD, Inc..

Semler Scientific, Inc. has a beta of 1.348, which suggesting that the stock is 34.774% more volatile than S&P 500. In comparison LifeMD, Inc. has a beta of 1.363, suggesting its more volatile than the S&P 500 by 36.256%.

Semler Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LifeMD, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Semler Scientific, Inc. pays -- of its earnings as a dividend. LifeMD, Inc. pays out 16.59% of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Semler Scientific, Inc. quarterly revenues are $7.5M, which are smaller than LifeMD, Inc. quarterly revenues of $60.2M. Semler Scientific, Inc.'s net income of $16.9M is higher than LifeMD, Inc.'s net income of -$3.6M. Notably, Semler Scientific, Inc.'s price-to-earnings ratio is 7.35x while LifeMD, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Semler Scientific, Inc. is 6.66x versus 0.66x for LifeMD, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -732.34% compared to Semler Scientific, Inc.'s net margin of -862.39%. Semler Scientific, Inc.'s return on equity of 18.3% beat VolitionRX Ltd.'s return on equity of --.

Semler Scientific, Inc. has a consensus price target of $65.67, signalling upside risk potential of 221.27%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.50 which suggests that it could grow by 779.04%. Given that VolitionRX Ltd. has higher upside potential than Semler Scientific, Inc., analysts believe VolitionRX Ltd. is more attractive than Semler Scientific, Inc..

Semler Scientific, Inc. has a beta of 1.348, which suggesting that the stock is 34.774% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Semler Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Semler Scientific, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Semler Scientific, Inc. quarterly revenues are $7.5M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Semler Scientific, Inc.'s net income of $16.9M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Semler Scientific, Inc.'s price-to-earnings ratio is 7.35x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Semler Scientific, Inc. is 6.66x versus 19.49x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -732.34% compared to Semler Scientific, Inc.'s net margin of -1037.17%. Semler Scientific, Inc.'s return on equity of 18.3% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Semler Scientific, Inc. has a consensus price target of $65.67, signalling upside risk potential of 221.27%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than Semler Scientific, Inc., analysts believe Catheter Precision, Inc. is more attractive than Semler Scientific, Inc..

Semler Scientific, Inc. has a beta of 1.348, which suggesting that the stock is 34.774% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Semler Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Semler Scientific, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Semler Scientific, Inc. quarterly revenues are $7.5M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Semler Scientific, Inc.'s net income of $16.9M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Semler Scientific, Inc.'s price-to-earnings ratio is 7.35x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Semler Scientific, Inc. is 6.66x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -732.34% compared to Semler Scientific, Inc.'s net margin of 3.93%. Semler Scientific, Inc.'s return on equity of 18.3% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Semler Scientific, Inc. has a consensus price target of $65.67, signalling upside risk potential of 221.27%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 150.92%. Given that Semler Scientific, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Semler Scientific, Inc. is more attractive than Xtant Medical Holdings, Inc..

Semler Scientific, Inc. has a beta of 1.348, which suggesting that the stock is 34.774% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Semler Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Semler Scientific, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Semler Scientific, Inc. quarterly revenues are $7.5M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Semler Scientific, Inc.'s net income of $16.9M is higher than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Semler Scientific, Inc.'s price-to-earnings ratio is 7.35x while Xtant Medical Holdings, Inc.'s PE ratio is 58.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Semler Scientific, Inc. is 6.66x versus 0.65x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.